Advancing Drug Discovery
We are building an end-to-end drug discovery pipeline for the future, using modern technologies, curated data, and a set of breakthrough algorithmic innovations to carry out most of the drug discovery in silico and make the whole process better, faster, cheaper, and more tailored. We have a cross-therapeutic approach, and have already helped address a variety of diseases including some rare diseases and cancers.
Drug discovery and drug development are among the most critical science activities contributing to better human health and wellbeing. However, the actual process has demonstrated to be exceedingly complex, expensive and time-consuming, which makes achievements such as delivering new, safe and efficient drugs to patients a rare event. Fortunately, recent AI computational advances have made the process of drug discovery and drug development more accessible, structured, and more intelligible.
In order to help advance the drug discovery process, we are building an end-to-end drug discovery pipeline for the future. By using modern technologies, curated data, and a set of in-house algorithmic innovations we make most of the drug discovery in silico and therefore making the whole process better, faster, cheaper, and more individualized.
Our solution employs in silico phenotypic screening for target identification, AI-based approaches for target validation, in silico High Throughput Screening (vHTS), selection of promising leads for upcoming clinical trials, and the use of genomic data to reduce clinical failure. Thanks to powerful AI techniques to handle and analyze big and complex data-carrying various biological information, the whole process is becoming less time-consuming, less expensive, and more insightful.
We have a unique approach to the problem: by assembling the whole drug discovery pipeline to be done mostly in silico, our solution can enhance the whole drug discovery process to much faster, cheaper, and less risky operation.
We help develop rapid and effective treatment for each and every human disease, building a drug discovery AI solution for all therapeutic areas including rare diseases and cancer.
We are experts in artificial intelligence, using state-of-the-art techniques and constantly innovating to bring the in silico drug discovery pipeline of the future.
Our technology: deep learning, transfer learning, novel featurization techniques, and curated datasets.
We are actively partnering with pharmaceutical, biotechnology companies, research and academic teams to accelerate their drug discovery process and develop innovative approaches to complex health diseases. If you are interested to learn more or have a specific project idea in mind, leave us a message!